Title |
Best practice guidelines for idiopathic nephrotic syndrome: recommendations versus reality
|
---|---|
Published in |
Pediatric Nephrology, August 2014
|
DOI | 10.1007/s00467-014-2903-7 |
Pubmed ID | |
Authors |
Andrea Pasini, Gabriella Aceto, Anita Ammenti, Gianluigi Ardissino, Vitalba Azzolina, Alberto Bettinelli, Elena Cama, Sante Cantatore, Antonella Crisafi, Giovanni Conti, Maria D’Agostino, Alessandra Dozza, Alberto Edefonti, Carmelo Fede, Elena Groppali, Chiara Gualeni, Alessandra Lavacchini, Marta Lepore, Silvio Maringhini, Paola Mariotti, Marco Materassi, Francesca Mencarelli, Giovanni Messina, Amata Negri, Marina Piepoli, Fiammetta Ravaglia, Angela Simoni, Laura Spagnoletta, Giovanni Montini, On behalf of the NefroKid Study Group |
Abstract |
The optimal therapeutic regimen for managing childhood idiopathic nephrotic syndrome (INS) is still under debate. We have evaluated the choice of steroid regimen and of symptomatic treatment adopted by pediatricians and pediatric nephrologists in a large number of centers as the first step towards establishing a shared protocol |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Colombia | 1 | 33% |
Unknown | 2 | 67% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Practitioners (doctors, other healthcare professionals) | 1 | 33% |
Science communicators (journalists, bloggers, editors) | 1 | 33% |
Members of the public | 1 | 33% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 88 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Other | 10 | 11% |
Student > Postgraduate | 9 | 10% |
Student > Master | 9 | 10% |
Student > Bachelor | 9 | 10% |
Student > Ph. D. Student | 7 | 8% |
Other | 25 | 28% |
Unknown | 19 | 22% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 45 | 51% |
Biochemistry, Genetics and Molecular Biology | 4 | 5% |
Nursing and Health Professions | 4 | 5% |
Agricultural and Biological Sciences | 4 | 5% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 3% |
Other | 3 | 3% |
Unknown | 25 | 28% |